Switch to:
Compare with: Competitors | Same P/E | Same P/S | Same Market Cap

Stocks under comparison: (Change symbols to compare, comma separated)

CompanyPfizer Inc (PFE) GlaxoSmithKline PLC (GSK) Johnson & Johnson (JNJ) Roche Holding AG (RHHBY) Novartis AG (NVS) Abbott Laboratories (ABT) 
Number of Guru Holders1,975 752 2,191 135 952 1,547 
Combined Weightings (%)1,956 242.16 3,318 75.57 573.62 865.83 
Number of Guru Buys:Sells (3 months)0 : 0  0 : 0   0 : 0 
Number of Guru Buys:Sells (6 months)0 : 0  0 : 0   0 : 0 
Number of Guru Buys:Sells (12 months)0 : 0  0 : 0   0 : 0 
Number of Insider Buys (3 months)
IndustryDrug Manufacturers - MajorDrug Manufacturers - MajorDrug Manufacturers - MajorBiotechnologyDrug Manufacturers - MajorMedical Devices
Price$29.10 $39.34 $101.97 $31.14 $72.62 $37 
Market Value ($mil)(Foreign currencies normalized to US$)$179,634 $95,789 $282,145 $212,255 $172,392 $55,194 
Enterprise Value ($mil)(Foreign currencies normalized to US$)$207,053 $103,455 $275,537 $215,253 $190,413 $58,175 
Revenue (mil)$48,851 $36,247 $70,074 $50,912 $50,387 $20,405 
P/E(ttm)21.86 6.69 19.46 24.09 10.01 12.37 
P/S3.82 2.76 4.09 4.23 3.48 2.72 
P/B2.65 12.16 3.97 10.08 2.21 2.61 
EV/EBIT20.66 6.93 18.25 17.21 23.61 23.24 
EV/Sales5.72 3.53 5.06 4.39 4.14 3.76 
Yield (%)3.92 6.11 2.90 3.23 3.65 2.65 
Payout0.83 0.39 0.56 0.74 0.93 0.56 
ROA (%)5.58 19.92 14.07 11.72 13.53 12.47 
ROE (%)13.26 169.17 25.90 43.70 23.52 24.04 
Operating Margin (%)25.06 47.29 26.09 27.42 17.80 14.05 
Net Margin (%)15.85 41.17 21.99 17.58 35.49 21.68 
Debt to Equity (%)58 304 28 111 29 40 
10-Year Rvn. Growth (%)4.20 4.70 1.80 0.40 
10-Year Earning Growth (%)0.60 -0.60 4.80 3.10 -0.20 -7 
5-Year Rvn. Growth (%)0.40 -2.50 3.30 2.20 -1.20 -11.80 
5-Year Earning Growth (%)6.80 4.10 0.60 -3.70 -26.30 
1-Year Rvn. Growth (%)-1.60 1.20 -4.90 1.20 -0.60 3.60 
1-Year Earning Growth (%)-17.30 136.50 -13.40 -4.90 -30.30 64.70 

Add this list into my watchlist/portfolio:

1. Add or remove tickers (Comma separated, up to 500 symbols)

2. Select destination portfolio


You need to log in to proceed

3. Click the button to finish



Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

User Comments

Daniel Seens
ReplyDaniel Seens - 1 year ago
PFE is trading at the low end of our short-term valuation range ($29-$36) and significantly below our Fair Value estimate of $42.41.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK